... company's stock worth $1,251,000 after buying an additional 137,830 shares during the last quarter. Ardsley Advisory Partners boosted its holdings in shares of CymaBay Therapeutics by 66.2% in the second quarter. Ardsley Advisory Partners now owns ...
https://www.americanbankingnews.com/2018/02/12/cymabay-therapeutics-inc-cbay-director-purchases-999999-00-in-stock.html
No comments:
Post a Comment